XTalks

APRIL 6, 2023

IRT solutions help clinical trial sponsors meet the complexities of patient randomization and clinical supply management. He also shared how modern software development concepts are impacting IRT platforms and transforming the user experience in clinical trials.

Clinical Trials 98

Clinical Trials Clinical Trials Clinical Supply Trials 98

Imperical Blog

SEPTEMBER 7, 2023

Avoiding “Customs Chaos” in Clinical Trials Means Working Closely with Your Importer of Record Many global clinical trial shipments get muddled regarding the critical role and responsibilities of the importer of record (IOR) for clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Imperical Blog

SEPTEMBER 7, 2023

Avoiding “Customs Chaos” in Clinical Trials Means Working Closely with Your Importer of Record Many global clinical trial shipments get muddled regarding the critical role and responsibilities of the importer of record (IOR) for clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

The Pharma Data

JANUARY 10, 2021

Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than 100 product candidates, of which 27 are currently in clinical development. For more information, please contact: SOURCE: MorphoSys AG via EQS Newswire.

Containment 52

Containment Clinical Development Antibody Development 52

The Pharma Data

AUGUST 15, 2021

Food and Drug Administration (FDA) has granted Fast Track designation to VTX-801, Vivet’s clinical-stage gene therapy for the treatment of Wilson Disease – a rare, genetic disorder that reduces the ability of the liver and other tissues to regulate copper levels, causing severe hepatic damage, neurological symptoms, and potentially death.

Gene Therapy 52

Gene Therapy Gene Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 24, 2021

Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally derived compound for the potential treatment of cancer, neurological, inflammatory and infectious diseases. Research and development efforts will be led by Dr. Paul Van Slyke.

Drugs 52

Drugs Containment Development Clinical Development 52

Cloudbyz

AUGUST 15, 2024

Managing Toxicity: Ensuring that supply logistics can accommodate the need for rapid adjustments in treatment due to toxicity or adverse events. How do RTSM systems support compliance with Good Manufacturing Practice (GMP) in clinical supply management?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Compliance 52